Table 5:
Age, y | MSD, Both Planes, mGy | SD, Both Planes, mGy | Brain Dose–to–MSD Conversion Factor | Brain-Absorbed Dose, mGy | Projected Risk of Developing Brain Tumors (×Baseline) |
---|---|---|---|---|---|
<1 | 372.9 | 361.2 | 0.48 | 164.4 | 4.8 |
1–2 | 443.5 | 434.4 | 0.38 | 160.0 | 4.7 |
3–7 | 383.3 | 398.9 | 0.30 | 93.3 | 3.2 |
8–12 | 355.3 | 341.9 | 0.25 | 74.1 | 2.7 |
13–17 | 521.3 | 529.7 | 0.24 | 103.9 | 3.4 |
18–21 | 583.5 | 729.3 | 0.23 | 106.3 | 3.4 |
All ages | 422.7 | 440 | 0.25 | 90.1 | 3.1 |
Note:—Projected risk is calculated as (excess relative risk = 0.023/mGy)+1.
SD indicates standard deviation (inter-patient variability).